Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by CleverInvestor2on May 09, 2020 12:09pm
139 Views
Post# 31006962

RE:General consensus?

RE:General consensus?
JusRob201 wrote: What's the general opinion here? I've been watching this stock for a month and might jump in with both feet. Is it worth holding back to see what happens? 


You should've taken my advice to buy a month ago... or even a couple weeks ago... You'd be up right now... Instead, you're on the outside speculating when to get in now that it's much more expensive.

General consensus is, if everything plays out as planned, trillium could be trading for $20-$30 in the coming years.

In the short term, I see some upside to this stock, up until news is released in June and then we'll see what happens...

Obviously there is risk buying now but there is still lots of money to be made.
<< Previous
Bullboard Posts
Next >>